Global Sirolimus Eluting Coronary Stent Market Growth 2025-2031

The global Sirolimus Eluting Coronary Stent market size is predicted to grow from US$ 109 million in 2025 to US$ 135 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.

The sirolimus-eluting coronary stent is a medical device used in interventional cardiovascular surgery and belongs to a type of drug-eluting stent. A coronary stent is a device used to treat narrowed or blocked coronary arteries that is placed in the coronary arteries by percutaneous coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI). A stent can help restore patency to blood vessels so blood flow can resume. Sirolimus is an immunosuppressant that inhibits cell proliferation. A sirolimus-eluting coronary stent is a drug-eluting stent whose surface is coated with the drug sirolimus. When a stent is placed in a narrowed coronary artery, sirolimus is gradually eluted and released onto the vessel wall. The drug release of sirolimus helps to inhibit cell proliferation within blood vessels, reducing the risk of restenosis, thereby increasing the long-lasting effect of the procedure.

LP Information, Inc. (LPI) ' newest research report, the “Sirolimus Eluting Coronary Stent Industry Forecast” looks at past sales and reviews total world Sirolimus Eluting Coronary Stent sales in 2024, providing a comprehensive analysis by region and market sector of projected Sirolimus Eluting Coronary Stent sales for 2025 through 2031. With Sirolimus Eluting Coronary Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sirolimus Eluting Coronary Stent industry.

This Insight Report provides a comprehensive analysis of the global Sirolimus Eluting Coronary Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sirolimus Eluting Coronary Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sirolimus Eluting Coronary Stent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sirolimus Eluting Coronary Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sirolimus Eluting Coronary Stent.

This report presents a comprehensive overview, market shares, and growth opportunities of Sirolimus Eluting Coronary Stent market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Balloon Diameter 2.25-3 mm
Balloon Diameter 3-4 mm
Others

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Cardionovum
Concept Medical
BIOTRONIK
Terumo Europe
Meril Life Sciences
eucatech AG
Eurocor Tech
MedAlliance
Boston Scientific
Abbott
Vasmed
Alvimedica
B. Braun
Balton

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sirolimus Eluting Coronary Stent market?

What factors are driving Sirolimus Eluting Coronary Stent market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sirolimus Eluting Coronary Stent market opportunities vary by end market size?

How does Sirolimus Eluting Coronary Stent break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.